{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:26:05Z","timestamp":1790472365226,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nephrotoxicity is a critical adverse event that leads to discontinuation of kinase inhibitor (KI) treatment. Here we show, through meta-analyses of FDA Adverse Event Reporting System, that dasatinib is associated with high risk for glomerular toxicity that is uncoupled from hypertension, suggesting a direct link between dasatinib and podocytes. We further investigate the cellular effects of dasatinib and other comparable KIs with varying risks of nephrotoxicity. Dasatinib treated podocytes show significant changes in focal adhesions, actin cytoskeleton, and morphology that are not observed with other KIs. We use phosphoproteomics and kinome profiling to identify the molecular mechanisms of dasatinib-induced injury to the actin cytoskeleton, and atomic force microscopy to quantify impairment to cellular biomechanics. Furthermore, chronic administration of dasatinib in mice causes reversible glomerular dysfunction, loss of stress fibers, and foot process effacement. We conclude that dasatinib induces nephrotoxicity through altered podocyte actin cytoskeleton, leading to injurious cellular biomechanics.<\/jats:p>","DOI":"10.1038\/s41467-019-09936-x","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T06:04:46Z","timestamp":1556863486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity"],"prefix":"10.1038","volume":"10","author":[{"given":"Rhodora C.","family":"Calizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smiti","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-7314","authenticated-orcid":false,"given":"J. G. Coen","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Cuttitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gomathi","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne H.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A.","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3608-5638","authenticated-orcid":false,"given":"Barbara","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk N.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6137-109X","authenticated-orcid":false,"given":"Evren U.","family":"Azeloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"9936_CR1","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/annonc\/mds027","volume":"23","author":"JJ Wheler","year":"2012","unstructured":"Wheler, J. J. et al. Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience. Ann. Oncol. 23, 1963\u20131967 (2012).","journal-title":"Ann. Oncol."},{"key":"9936_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1681\/ASN.2008090998","volume":"20","author":"G Wong","year":"2009","unstructured":"Wong, G. et al. Association of CKD and cancer risk in older people. J. Am. Soc. Nephrol. 20, 1341\u20131350 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9936_CR3","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/annonc\/mdv136","volume":"26","author":"V Launay-Vacher","year":"2015","unstructured":"Launay-Vacher, V. et al. Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN). Ann. Oncol. 26, 1677\u20131684 (2015).","journal-title":"Ann. Oncol."},{"key":"9936_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11523-015-0368-7","volume":"10","author":"A Abbas","year":"2015","unstructured":"Abbas, A., Mirza, M. M., Ganti, A. K. & Tendulkar, K. Renal toxicities of targeted therapies. Target Oncol. 10, 487\u2013499 (2015).","journal-title":"Target Oncol."},{"key":"9936_CR5","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1001\/jama.2017.5150","volume":"317","author":"NS Downing","year":"2017","unstructured":"Downing, N. S. et al. Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA 317, 1854\u20131863 (2017).","journal-title":"JAMA"},{"key":"9936_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 81, 442\u2013448 (2012).","journal-title":"Kidney Int."},{"key":"9936_CR7","doi-asserted-by":"publisher","first-page":"206ra140","DOI":"10.1126\/scitranslmed.3006548","volume":"5","author":"S Zhao","year":"2013","unstructured":"Zhao, S. et al. Systems pharmacology of adverse event mitigation by drug combinations. Sci. Transl. Med. 5, 206ra140 (2013).","journal-title":"Sci. Transl. Med."},{"key":"9936_CR8","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091\u2013D1097 (2014).","journal-title":"Nucleic Acids Res."},{"key":"9936_CR9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1053\/j.ajkd.2013.01.022","volume":"61","author":"E Wallace","year":"2013","unstructured":"Wallace, E., Lyndon, W., Chumley, P., Jaimes, E. A. & Fatima, H. Dasatinib-induced nephrotic-range proteinuria. Am. J. Kidney Dis. 61, 1026\u20131031 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"9936_CR10","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1016\/j.ejca.2006.09.015","volume":"42","author":"FA Eskens","year":"2006","unstructured":"Eskens, F. A. & Verweij, J. The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review. Eur. J. Cancer 42, 3127\u20133139 (2006).","journal-title":"Eur. J. Cancer"},{"key":"9936_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.ki.5002291","volume":"72","author":"SJ Shankland","year":"2007","unstructured":"Shankland, S. J., Pippin, J. W., Reiser, J. & Mundel, P. Podocytes in culture: past, present, and future. Kidney Int. 72, 26\u201336 (2007).","journal-title":"Kidney Int."},{"key":"9936_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1681\/ASN.2014020192","volume":"26","author":"J Chen","year":"2015","unstructured":"Chen, J., Chen, J. K. & Harris, R. C. EGF receptor deletion in podocytes attenuates diabetic nephropathy. J. Am. Soc. Nephrol. 26, 1115\u20131125 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9936_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1440-1797.2011.01451.x","volume":"16","author":"A Advani","year":"2011","unstructured":"Advani, A. et al. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy. Nephrology 16, 573\u2013581 (2011).","journal-title":"Nephrology"},{"key":"9936_CR14","doi-asserted-by":"publisher","first-page":"e48929","DOI":"10.1371\/journal.pone.0048929","volume":"7","author":"AM McCaig","year":"2012","unstructured":"McCaig, A. M., Cosimo, E., Leach, M. T. & Michie, A. M. Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12. PLoS One 7, e48929 (2012).","journal-title":"PLoS One"},{"key":"9936_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02218-4","volume":"8","author":"A Ron","year":"2017","unstructured":"Ron, A. et al. Cell shape information is transduced through tension-independent mechanisms. Nat. Commun. 8, 2145 (2017).","journal-title":"Nat. Commun."},{"key":"9936_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-4939-0685-7_14","volume":"1156","author":"L Arike","year":"2014","unstructured":"Arike, L. & Peil, L. Spectral counting label-free proteomics. Methods Mol. Biol. 1156, 213\u2013222 (2014).","journal-title":"Methods Mol. Biol."},{"key":"9936_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).","journal-title":"BMC Bioinform."},{"key":"9936_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nbt.2017","volume":"29","author":"T Anastassiadis","year":"2011","unstructured":"Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H. & Peterson, J. R. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol. 29, 1039\u20131045 (2011).","journal-title":"Nat. Biotechnol."},{"key":"9936_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/31735","volume":"393","author":"N Yang","year":"1998","unstructured":"Yang, N. et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393, 809\u2013812 (1998).","journal-title":"Nature"},{"key":"9936_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/12963","volume":"1","author":"DC Edwards","year":"1999","unstructured":"Edwards, D. C., Sanders, L. C., Bokoch, G. M. & Gill, G. N. Activation of LIM-kinase by Pak1 couples Rac\/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat. Cell Biol. 1, 253\u2013259 (1999).","journal-title":"Nat. Cell Biol."},{"key":"9936_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/31729","volume":"393","author":"S Arber","year":"1998","unstructured":"Arber, S. et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393, 805\u2013809 (1998).","journal-title":"Nature"},{"key":"9936_CR22","doi-asserted-by":"publisher","first-page":"22676","DOI":"10.1074\/jbc.M110.122929","volume":"285","author":"P Garg","year":"2010","unstructured":"Garg, P. et al. Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture. J. Biol. Chem. 285, 22676\u201322688 (2010).","journal-title":"J. Biol. Chem."},{"key":"9936_CR23","doi-asserted-by":"publisher","first-page":"F951","DOI":"10.1152\/ajprenal.00536.2009","volume":"298","author":"J Zhu","year":"2010","unstructured":"Zhu, J. et al. p21-activated kinases regulate actin remodeling in glomerular podocytes. Am. J. Physiol. Ren. Physiol. 298, F951\u2013F961 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"9936_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1152\/japplphysiol.00958.2007","volume":"105","author":"EU Azeloglu","year":"2008","unstructured":"Azeloglu, E. U., Bhattacharya, J. & Costa, K. D. Atomic force microscope elastography reveals phenotypic differences in alveolar cell stiffness. J. Appl Physiol. 105, 652\u2013661 (2008).","journal-title":"J. Appl Physiol."},{"key":"9936_CR25","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41388-017-0071-5","volume":"37","author":"JS Logue","year":"2018","unstructured":"Logue, J. S., Cartagena-Rivera, A. X. & Chadwick, R. S. c-Src activity is differentially required by cancer cell motility modes. Oncogene 37, 2104\u20132121 (2018).","journal-title":"Oncogene"},{"key":"9936_CR26","doi-asserted-by":"publisher","first-page":"e0132724","DOI":"10.1371\/journal.pone.0132724","volume":"10","author":"R Liao","year":"2015","unstructured":"Liao, R. et al. Tacrolimus protects podocytes from injury in lupus nephritis partly by stabilizing the cytoskeleton and inhibiting podocyte apoptosis. PLoS One 10, e0132724 (2015).","journal-title":"PLoS One"},{"key":"9936_CR27","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1093\/ndt\/gfp427","volume":"24","author":"S Trivedi","year":"2009","unstructured":"Trivedi, S., Zeier, M. & Reiser, J. Role of podocytes in lupus nephritis. Nephrol. Dial. Transpl. 24, 3607\u20133612 (2009).","journal-title":"Nephrol. Dial. Transpl."},{"key":"9936_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/10715769009053373","volume":"8","author":"G Bellomo","year":"1990","unstructured":"Bellomo, G. et al. The cytoskeleton as a target in quinone toxicity. Free Radic. Res. Commun. 8, 391\u2013399 (1990).","journal-title":"Free Radic. Res. Commun."},{"key":"9936_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tcb.2007.06.006","volume":"17","author":"C Faul","year":"2007","unstructured":"Faul, C., Asanuma, K., Yanagida-Asanuma, E., Kim, K. & Mundel, P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 17, 428\u2013437 (2007).","journal-title":"Trends Cell Biol."},{"key":"9936_CR30","doi-asserted-by":"publisher","first-page":"e1005433","DOI":"10.1371\/journal.pcbi.1005433","volume":"13","author":"CV Falkenberg","year":"2017","unstructured":"Falkenberg, C. V. et al. Fragility of foot process morphology in kidney podocytes arises from chaotic spatial propagation of cytoskeletal instability. PLoS Comput Biol. 13, e1005433 (2017).","journal-title":"PLoS Comput Biol."},{"key":"9936_CR31","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1681\/ASN.2005020159","volume":"16","author":"D Yu","year":"2005","unstructured":"Yu, D. et al. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J. Am. Soc. Nephrol. 16, 1733\u20131741 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9936_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda, T., Tamon, A., Kadoyama, K. & Okuno, Y. Data mining of the public version of the FDA adverse event reporting system. Int J. Med Sci. 10, 796\u2013803 (2013).","journal-title":"Int J. Med Sci."},{"key":"9936_CR33","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1158\/1078-0432.CCR-09-0224","volume":"15","author":"GD Demetri","year":"2009","unstructured":"Demetri, G. D. et al. Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors. Clin. Cancer Res. 15, 6232\u20136240 (2009).","journal-title":"Clin. Cancer Res."},{"key":"9936_CR34","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.leukres.2008.07.029","volume":"33","author":"SA Holstein","year":"2009","unstructured":"Holstein, S. A., Stokes, J. B. & Hohl, R. J. Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia. Leuk. Res. 33, 344\u2013347 (2009).","journal-title":"Leuk. Res."},{"key":"9936_CR35","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1021\/jm049486a","volume":"47","author":"LJ Lombardo","year":"2004","unstructured":"Lombardo, L. J. et al. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J. Med. Chem. 47, 6658\u20136661 (2004).","journal-title":"J. Med. Chem."},{"key":"9936_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature08908","volume":"463","author":"DA Fletcher","year":"2010","unstructured":"Fletcher, D. A. & Mullins, R. D. Cell mechanics and the cytoskeleton. Nature 463, 485\u2013492 (2010).","journal-title":"Nature"},{"key":"9936_CR37","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nmat3772","volume":"12","author":"T Luo","year":"2013","unstructured":"Luo, T., Mohan, K., Iglesias, P. A. & Robinson, D. N. Molecular mechanisms of cellular mechanosensing. Nat. Mater. 12, 1064\u20131071 (2013).","journal-title":"Nat. Mater."},{"key":"9936_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/MNH.0b013e3283624820","volume":"22","author":"K Soda","year":"2013","unstructured":"Soda, K. & Ishibe, S. The function of endocytosis in podocytes. Curr. Opin. Nephrol. Hypertens. 22, 432\u2013438 (2013).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"9936_CR39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ceb.2006.04.009","volume":"18","author":"F Miralles","year":"2006","unstructured":"Miralles, F. & Visa, N. Actin in transcription and transcription regulation. Curr. Opin. Cell Biol. 18, 261\u2013266 (2006).","journal-title":"Curr. Opin. Cell Biol."},{"key":"9936_CR40","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrneph.2016.127","volume":"12","author":"L Perico","year":"2016","unstructured":"Perico, L., Conti, S., Benigni, A. & Remuzzi, G. Podocyte-actin dynamics in health and disease. Nat. Rev. Nephrol. 12, 692\u2013710 (2016).","journal-title":"Nat. Rev. Nephrol."},{"issue":"51","key":"9936_CR41","doi-asserted-by":"publisher","first-page":"21137","DOI":"10.1074\/jbc.M117.819029","volume":"292","author":"Kristin Meliambro","year":"2017","unstructured":"Meliambro, K., et al. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. J. Biol. Chem.\u00a0292, 21137\u201321148 (2017).","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"9936_CR42","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1681\/ASN.2017050475","volume":"29","author":"Addie E. Embry","year":"2018","unstructured":"Embry, A. E., et al. Similar biophysical abnormalities in Glomeruli and podocytes from two distinct models. J. Am. Soc. Nephrol.\u00a029, 1501\u20131512 (2018).","journal-title":"Journal of the American Society of Nephrology"},{"key":"9936_CR43","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","volume":"69","author":"SJ Shankland","year":"2006","unstructured":"Shankland, S. J. The podocyte\u2019s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 69, 2131\u20132147 (2006).","journal-title":"Kidney Int."},{"key":"9936_CR44","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/j.1523-1755.2004.00964.x","volume":"66","author":"JG van den Berg","year":"2004","unstructured":"van den Berg, J. G., van den Bergh Weerman, M. A., Assmann, K. J., Weening, J. J. & Florquin, S. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int. 66, 1901\u20131906 (2004).","journal-title":"Kidney Int."},{"key":"9936_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000369309","volume":"129","author":"C Tondel","year":"2015","unstructured":"Tondel, C. et al. Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria. Nephron 129, 16\u201321 (2015).","journal-title":"Nephron"},{"key":"9936_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.ajkd.2012.03.014","volume":"60","author":"J Jones","year":"2012","unstructured":"Jones, J. et al. Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality. Am. J. Kidney Dis. 60, 402\u2013408 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"9936_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nbt.3623","volume":"34","author":"M Sarangdhar","year":"2016","unstructured":"Sarangdhar, M. et al. Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data. Nat. Biotechnol. 34, 697\u2013700 (2016).","journal-title":"Nat. Biotechnol."},{"key":"9936_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown, E. G., Wood, L. & Wood, S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 20, 109\u2013117 (1999).","journal-title":"Drug Saf."},{"key":"9936_CR49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.V85697","volume":"8","author":"P Mundel","year":"1997","unstructured":"Mundel, P., Reiser, J. & Kriz, W. Induction of differentiation in cultured rat and human podocytes. J. Am. Soc. Nephrol. 8, 697\u2013705 (1997).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9936_CR50","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1681\/ASN.2013111179","volume":"26","author":"K Lee","year":"2015","unstructured":"Lee, K., Boctor, S., Barisoni, L. M. & Gusella, G. L. Inactivation of integrin-beta1 prevents the development of polycystic kidney disease after the loss of polycystin-1. J. Am. Soc. Nephrol. 26, 888\u2013895 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9936_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ki.2015.106","volume":"88","author":"J Xie","year":"2015","unstructured":"Xie, J. et al. Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosis. Kidney Int. 88, 593\u2013604 (2015).","journal-title":"Kidney Int."},{"key":"9936_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).","journal-title":"Genome Biol."},{"key":"9936_CR53","first-page":"135","volume":"9","author":"W Zhou","year":"2012","unstructured":"Zhou, W., Liotta, L. A. & Petricoin, E. F. The spectra count label-free quantitation in cancer proteomics. Cancer Genom. Proteom. 9, 135\u2013142 (2012).","journal-title":"Cancer Genom. Proteom."},{"key":"9936_CR54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"9936_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bioinformatics\/btr625","volume":"28","author":"EY Chen","year":"2012","unstructured":"Chen, E. Y. et al. Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics 28, 105\u2013111 (2012).","journal-title":"Bioinformatics"},{"key":"9936_CR56","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-61779-105-5_19","volume":"736","author":"EU Azeloglu","year":"2011","unstructured":"Azeloglu, E. U. & Costa, K. D. Atomic force microscopy in mechanobiology: measuring microelastic heterogeneity of living cells. Methods Mol. Biol. 736, 303\u2013329 (2011).","journal-title":"Methods Mol. Biol."},{"key":"9936_CR57","doi-asserted-by":"publisher","first-page":"H853","DOI":"10.1152\/ajpheart.00427.2009","volume":"298","author":"EU Azeloglu","year":"2010","unstructured":"Azeloglu, E. U. & Costa, K. D. Cross-bridge cycling gives rise to spatiotemporal heterogeneity of dynamic subcellular mechanics in cardiac myocytes probed with atomic force microscopy. Am. J. Physiol. Heart Circ. Physiol. 298, H853\u2013H860 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"9936_CR58","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/S0006-3495(02)75620-8","volume":"82","author":"EK Dimitriadis","year":"2002","unstructured":"Dimitriadis, E. K., Horkay, F., Maresca, J., Kachar, B. & Chadwick, R. S. Determination of elastic moduli of thin layers of soft material using the atomic force microscope. Biophys. J. 82, 2798\u20132810 (2002).","journal-title":"Biophys. J."},{"key":"9936_CR59","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nnano.2012.163","volume":"7","author":"N Gavara","year":"2012","unstructured":"Gavara, N. & Chadwick, R. S. Determination of the elastic moduli of thin samples and adherent cells using conical atomic force microscope tips. Nat. Nanotechnol. 7, 733\u2013736 (2012).","journal-title":"Nat. Nanotechnol."},{"key":"9936_CR60","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1115\/1.2835074","volume":"121","author":"KD Costa","year":"1999","unstructured":"Costa, K. D. & Yin, F. C. Analysis of indentation: implications for measuring mechanical properties with atomic force microscopy. J. Biomech. Eng. 121, 462\u2013471 (1999).","journal-title":"J. Biomech. Eng."},{"key":"9936_CR61","doi-asserted-by":"publisher","first-page":"ra12","DOI":"10.1126\/scisignal.2004621","volume":"7","author":"EU Azeloglu","year":"2014","unstructured":"Azeloglu, E. U. et al. Interconnected network motifs control podocyte morphology and kidney function. Sci. Signal. 7, ra12 (2014).","journal-title":"Sci. Signal."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09936-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09936-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09936-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T12:03:18Z","timestamp":1721217798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09936-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9936"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09936-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735679819.793566386","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2061"}}